CW ClaimWatch Consumer alert tracker

Recall

Wells Pharma of Houston LLC: fentaNYL Citrate Injectable Solution in 0.9% Sodium Chloride, 50 mcg/5mL)(10 mcg per mL), wells pharma, Recall

cGMP deviations. Product details: fentaNYL Citrate Injectable Solution in 0.9% Sodium Chloride, 50 mcg/5mL)(10 mcg per mL), wells pharma, NDC 73702-202-15.

Active Official source

Verification

Official-source record

This page is included in the public index because it is tied to a listed official source. ClaimWatch does not publish trend-only candidates to public SEO pages.

Agency
FDA
Record ID
D-0508-2026
Canonical
https://claimwatch-mvp.vercel.app/item/wells-pharma-of-houston-llc-fentanyl-citrate-injectable-solution-in-0-9-sodium-chloride-50/

What happened?

cGMP deviations. Product details: fentaNYL Citrate Injectable Solution in 0.9% Sodium Chloride, 50 mcg/5mL)(10 mcg per mL), wells pharma, NDC 73702-202-15.

Who may be affected?

U.S. Nationwide.

What should consumers do?

Affected quantity: 50 syringes

Official source

Matched search terms

No search trend terms attached yet.

FAQ

Is this page official?

No. ClaimWatch links to official sources and marks whether a page is verified or still being monitored.

Is this legal, medical, or financial advice?

No. This page is informational. Always confirm eligibility, deadlines, and safety instructions through official sources.

Similar alerts